From persevering with a tricky Alzheimer’s program to securing a late-stage CD38-directed antibody and posting encouraging lupus data, Biogen has…

Mere months after obesity biotech Kailera Therapeutics netted the biggest initial public offering the sector has ever seen, with a…

Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma…

When looking out across the competitive GLP-1 landscape, AstraZeneca might not be the first Big Pharma name that comes to…

Ernst & Young is projecting biotech revenues will grow by at least 12% in 2026, recording growth for the third…

In a groundbreaking study published in BMC Geriatrics, a team of researchers led by Kantha, Lapanan, Phongjit, and colleagues has…

In a groundbreaking advance in cancer treatment, researchers have unveiled the promising therapeutic potential of photoimmunotherapy targeting solid tumors expressing…

As the global population ages, one of the most pressing public health challenges is addressing the health and wellbeing of…

A groundbreaking study published in the Journal of Studies on Alcohol and Drugs has delivered a decisive message challenging widespread…

A groundbreaking study recently published in the Journal of Studies on Alcohol and Drugs has delivered a sobering reassessment of…